Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Weight-Loss Drugs Like Ozempic Are Powerful, but a Simple Health Fix May Be Better

In the past five years, several new drugs have been brought to market that could lead to a profound, if not revolutionary, change in how healthcare providers – and the public – view weight loss.

Inverse

FDA advisers say new Alzheimer’s drug lecanemab slows cognitive decline

Panel’s opinion could pave way for full regulatory approval next month for treatment of disease that affects 6.5m Americans

The Guardian - US

Amy Schumer reveals she tried Ozempic while calling out celebrities for not being ‘real’ about weight loss

Ozempic is a once-weekly injection used for the treatment of type 2 diabetes, though some of its side effects include weight loss

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures Rise: Bullish Market Breadth, But Fed Looms; Nvidia Has New Buy Point

A broader market rally is a reason to be bullish long term, but the Fed meeting is one reason to be cautious now. Biogen jumped late Friday. Watch Tesla and Nvidia.

Investors Business Daily

Experimental Alzheimer's drug endorsed for full approval by FDA advisers

Leqembi could become the first treatment of its kind to receive traditional approval from the FDA.

Axios

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

U.S. health advisers are backing the full approval of an Alzheimer's drug that received preliminary approval last year

The Independent UK

Biogen Rises After 'Drama-Free' Panel Votes Unanimously In Support Of Alzheimer's Drug

Biogen stock rose Monday after a panel of advisors to the FDA voted unanimously in favor of its newest Alzheimer's treatment.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Crispr Stock Slips; The FDA Could Approve The First CRISPR-Based Gene-Editing Drug In Just Six Months

The FDA could approve Crispr Therapeutics' gene-edited sickle cell treatment as early as December. In response, CRSP stock surged Friday.

Investors Business Daily

FDA advisers endorse new RSV antibody drug for babies

A panel of experts to the Food and Drug Administration has recommended the agency approve a long-acting antibody drug that can protect infants from the seasonal virus, RSV.

WEKU

Vote on plans to bar MPs accused of sexual or violent offences delayed

Staff will be left at risk if proposals to ban members under police investigation from Westminster estate dropped, unions say

The Guardian - UK

Inside the World of Ambitious Aging

Biohacking promises to make you feel and look decades younger. So what's the catch?

Marie Claire

Biogen Rises As 'Relatively Benign' FDA Documents Suggest An Alzheimer's Approval Is Near

Biogen stock rose Wednesday after the FDA posted documents that suggest the agency will approve Alzheimer's treatment Leqembi.

Investors Business Daily

3 Undervalued Pharma Stocks Worth Buying

With the growing prevalence of chronic diseases, the adoption of advanced digital technologies, and new drug discoveries, the pharmaceutical industry is set to witness significant growth this year and beyond. Thus, it could be wise to invest in quality pharma stocks Ipsen (IPSEY), Supernus (SUPN), and Kamada (KMDA), which are…

StockNews.com

The anti-vaxxer threat keeps spreading

With vaccines on the horizon, RSV could finally be preventable. But anti-vax misinfo could get in the way

Salon

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

AI in medicine needs to be carefully deployed to counter bias – and not entrench it

Powerful new artificial intelligence tools can perpetuate long-standing racial inequities if they are not designed very carefully. Researchers and regulators are taking note, but perils are vast.

Inverse

This Herbal Supplement is Hailed as "Nature's Ozempic," but How Safe is It?

TikTokers are using the dietary supplement berberine, calling it "nature's Ozempic" as a weight-loss drug that's cheaper and easier to attain.

Inverse

Elon Musk's Neuralink Brain Implant Approved for Human Trials in the US — Is It Safe?

The implant sends their brain signals via Bluetooth to a computer, which then translates their intended action into tasks on a computer.

Evening Standard

Brain implants: The reality behind Elon Musk’s sci-fi dreams of mind control

Elon Musk’s Neuralink has brought a lot of attention to the world of brain-computer interfaces but whether we need implants in our heads is debatable.

Get all your
news in one place.

100’s of premium titles.
One news app.

Inverse

The FDA Just Approved a Game-Changing OTC Birth Control Pill — Should You Switch to It?

The Opill contains a low dose of progestin at 0.075 milligrams per pill, and has to be taken at the same time every day.

The Guardian - US

Elon Musk’s brain implant company is approved for human testing. How alarmed should we be?

The billionaire’s record has raised concerns over Neuralink’s ability to responsibly oversee the development of such an invasive device

Salon

Next COVID vax might drop OG strain

Scientists debate the benefits of bivalent and monovalent shots

LiveScience

Elon Musk's Neuralink 'brain chips' cleared for 1st in-human trials

Brain implants developed by Elon Musk's company Neuralink have been approved for human testing. The safety of the devices previously came under scrutiny following reports of "botched surgeries" in animal test subjects.

The Guardian - US

Health advocates urge US regulators to ban common food coloring additive

Titanium dioxide, found in candy, meat substitutes and packaged cookies, has been linked to a range of serious health issues

LiveScience

Watch out for Ozempic copycats containing unauthorized active ingredients, FDA warns

Some compounding pharmacies are using unauthorized active ingredients to make copycat versions of Ozempic and Wegovy.

The Independent UK

FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss

FDA has warned consumers against using ‘compounded’ versions of semaglutide, the key ingredient found in Ozempic and Wegovy

1 … 89 90 91 92

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.